AVAX (ATH:AVAX) Accounts Payable & Accrued Expense: €386.6 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ATH:AVAX AVAX SA ATH:AVAX
64 GF Score
Price €3.36
GF Value €2.90
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is AVAX Accounts Payable & Accrued Expense?

AVAX ATH:AVAX -3.59% 64 Accounts Payable & Accrued Expense is €386.6 Mil as of Dec. 2025. GuruFocus rates ATH:AVAX with a GF Score™ of 64/100 and a GF Value™ of €2.90 (Modestly Overvalued). The stock has 5 warning signs investors should review.

AVAX's quarterly accounts payable & accrued expense declined from Dec. 2024 (€353.4 Mil) to Jun. 2025 (€275.3 Mil) but then increased from Jun. 2025 (€275.3 Mil) to Dec. 2025 (€386.6 Mil).

AVAX's annual accounts payable & accrued expense increased from Dec. 2023 (€346.5 Mil) to Dec. 2024 (€353.4 Mil) and increased from Dec. 2024 (€353.4 Mil) to Dec. 2025 (€386.6 Mil).

AVAX Accounts Payable & Accrued Expense Historical Data

* Premium members only.

The historical data trend for AVAX's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AVAX Accounts Payable & Accrued Expense Chart

AVAX Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 239.40 241.32 346.49 353.43 386.63

AVAX Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 346.49 329.47 353.43 275.26 386.63
ATH:AVAX
64GF Score
AVAX SA ATH:AVAX
Accounts Payable & Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AVAX Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

What does a Accounts Payable & Accrued Expense of €386.6 Mil mean?
AVAX (ATH:AVAX) has a Accounts Payable & Accrued Expense of €386.6 Mil as of Dec. 2025. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on AVAX and its competitors.
Is AVAX's Accounts Payable & Accrued Expense too high?
AVAX's current Accounts Payable & Accrued Expense is €386.6 Mil. Overall, AVAX has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AVAX's Accounts Payable & Accrued Expense compare to PWR and FIX?
AVAX's Accounts Payable & Accrued Expense of €386.6 Mil can be compared against companies in the Construction industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable & Accrued Expense for a Construction company?
A good Accounts Payable & Accrued Expense depends on the Construction industry context. However, Accounts Payable & Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable & Accrued Expense mean?
A high Accounts Payable & Accrued Expense can signal that a stock is expensive relative to its fundamentals. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on AVAX and its competitors. AVAX's current Accounts Payable & Accrued Expense is €386.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AVAX stock overvalued right now?
Based on GuruFocus' analysis, AVAX (ATH:AVAX) is currently considered Modestly Overvalued. The stock's GF Value™ is €2.90, compared to a current price of €3.36 — trading 15.9% above its estimated fair value. The current Accounts Payable & Accrued Expense is €386.6 Mil. AVAX's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable & Accrued Expense calculated?
Accounts Payable & Accrued Expense is calculated from a company's financial statements. For AVAX (ATH:AVAX), the current Accounts Payable & Accrued Expense is €386.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AVAX (ATH:AVAX) Overvalued in 2026?

Based on GuruFocus' analysis, AVAX stock appears to be overvalued. The current stock price of €3.36 is trading 15.9% above its estimated GF Value™ of €2.90. GuruFocus considers AVAX to be Modestly Overvalued.

Key valuation signals for ATH:AVAX:

  • Accounts Payable & Accrued Expense: €386.6 Mil
  • GF Value™: €2.90 vs. price of €3.36 (15.9% above fair value)
  • GF Score™: 64/100 with 5 warning signs

No single metric tells the full story. See the ATH:AVAX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AVAX Business Description

Other Exchanges 0DO2:UKIJ6:Germany
Address 16 Amaroussiou, Halandriou Street, Marousi, GRC, 15125
AVAX SA operates as a construction company in Greece. The company operates through the following segments: The Construction segment develops buildings, warehouses, and shopping centers; The Concessions segment constructs highways, bridges, airports, and car parks; The Energy segment comprises of the construction TAP natural gas pipeline in Northern Greece; design and construction of power plants in Iraq; TheReal Estate segment covers estate development and other activities. It derives maximum revenue from the Construction segment.
64GF Score

Get the complete analysis for ATH:AVAX

Accounts Payable & Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.36
Price
€2.90
GF Value